BofA Securities initiated coverage on Turnstone Biologics with a new price target

8/15/23 7:35:19 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

BofA Securities initiated coverage of Turnstone Biologics with a rating of Buy and set a new price target of $18.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TSBX

Date	Price Target	Rating	Analyst
2/5/2025	$3.75 → $0.40	Overweight → Neutral	Piper Sandler
11/15/2024		Neutral → Underperform	BofA Securities
10/14/2024		Buy → Neutral	BofA Securities
8/16/2023		Market Perform	SVB Securities
8/15/2023	$20.00	Overweight	Piper Sandler
8/15/2023	$18.00	Buy	BofA Securities